[A case of long survival with unresectable duodenal papilla cancer treated with oral chemotherapy using combination UFT and cyclophosphamide]

Gan To Kagaku Ryoho. 2008 Aug;35(8):1399-401.
[Article in Japanese]

Abstract

A 69-year-old female patient underwent a choledochojejunostomy for unresectable duodenal papilla cancer with para-aortic lymph node metastases. Both tegafur-uracil(UFT) and cyclophosphamide were given orally every day after surgery. Twenty-eight months from the initiation of the chemotherapy the tumor had remarkably reduced and the objective response was evaluated as a PR. The patient is now doing well. Lymph node metastasis is considered an important prognostic factor of papilla Vater carcinoma, and especially with para-aortic lymph node metastases the long-term prognosis is poor. Combination chemotherapy using UFT and cyclophosphamide would be a therapeutic option for elderly or high-risk patients.

Publication types

  • Case Reports

MeSH terms

  • Adenoma / drug therapy*
  • Adenoma / pathology
  • Administration, Oral
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Biomarkers, Tumor / blood
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Duodenal Neoplasms / blood
  • Duodenal Neoplasms / diagnostic imaging
  • Duodenal Neoplasms / drug therapy*
  • Duodenal Neoplasms / pathology
  • Duodenoscopy
  • Female
  • Humans
  • Tegafur / administration & dosage
  • Tegafur / therapeutic use*
  • Time Factors
  • Tomography, X-Ray Computed
  • Uracil / administration & dosage
  • Uracil / therapeutic use*

Substances

  • Biomarkers, Tumor
  • Tegafur
  • Uracil
  • Cyclophosphamide